Literature DB >> 9253702

Origin and transmission of methicillin-resistant Staphylococcus aureus in an endemic situation: differences between geriatric and intensive-care patients.

A Hoefnagels-Schuermans1, A Borremans, W Peetermans, S Van Lierde, G Reybrouck, J Van Eldere.   

Abstract

Imported vs. hospital-acquisition of MRSA was assessed in > 6000 patients at a large tertiary care teaching hospital. About five percent (5.1%) of patients carried MRSA on admission, mostly without clinical symptoms; the highest percentage (11.6%) being in geriatric patients. Hospital-acquisition of MRSA occurred in 1.7% of patients and was particularly high in intensive-care units (5.2%). Phenotype and genotype analysis of 158 MRSA strains isolated from 61 patients revealed a cluster of closely related strains in the hospital-acquired MRSA infections and the close relationship of this cluster to the regional epidemic MRSA strain. The MRSA strains imported by geriatric patients were genetically different, did not spread between geriatric patients and were only a minor source of nosocomial infection.

Entities:  

Mesh:

Year:  1997        PMID: 9253702     DOI: 10.1016/s0195-6701(97)90196-1

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  10 in total

1.  Clonal analysis and identification of epidemic strains of methicillin-resistant Staphylococcus aureus by antibiotyping and determination of protein A gene and coagulase gene polymorphisms.

Authors:  A Hoefnagels-Schuermans; W E Peetermans; M J Struelens; S Van Lierde; J Van Eldere
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

2.  Genetic Lineages of Methicillin-Resistant Staphylococcus aureus Acquired during Admission to an Intensive Care Unit of a General Hospital.

Authors:  Wadha Alfouzan; Rita Dhar; Edet Udo
Journal:  Med Princ Pract       Date:  2016-11-08       Impact factor: 1.927

Review 3.  Epidemiology of MRSA.

Authors:  W Hryniewicz
Journal:  Infection       Date:  1999       Impact factor: 3.553

4.  Identification of a novel methicillin-resistant Staphylococcus aureus epidemic clone in Córdoba, Argentina, involved in nosocomial infections.

Authors:  Claudia Sola; Germán Gribaudo; Ana Vindel; Luis Patrito; José Luis Bocco
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

5.  Methicillin-resistant Staphylococcus aureus in a general intensive care unit.

Authors:  D S Thompson
Journal:  J R Soc Med       Date:  2004-11       Impact factor: 18.000

6.  MRSA in a large German University Hospital: Male gender is a significant risk factor for MRSA acquisition.

Authors:  Markus Kupfer; Lutz Jatzwauk; Stephan Monecke; Jana Möbius; Axel Weusten
Journal:  GMS Krankenhhyg Interdiszip       Date:  2010-09-21

7.  Microbiological, Clinical and Radiological Aspects of Diabetic Foot Ulcers Infected with Methicillin-Resistant and -Sensitive Staphylococcus aureus.

Authors:  Maria Stańkowska; Katarzyna Garbacz; Anna Korzon-Burakowska; Marek Bronk; Monika Skotarczak; Anna Szymańska-Dubowik
Journal:  Pathogens       Date:  2022-06-17

8.  A randomized controlled trial of tea tree oil (5%) body wash versus standard body wash to prevent colonization with methicillin-resistant Staphylococcus aureus (MRSA) in critically ill adults: research protocol.

Authors:  Gillian Thompson; Bronagh Blackwood; Ronan McMullan; Fiona A Alderdice; T John Trinder; Gavin G Lavery; Danny F McAuley
Journal:  BMC Infect Dis       Date:  2008-11-28       Impact factor: 3.090

9.  Is first-line antimicrobial therapy still adequate to treat MRSA in the ICU? A report from a highly endemic country.

Authors:  Matteo Bassetti; Elda Righi; Maddalena Peghin; Alessia Carnelutti; Filippo Ansaldi; Cecilia Trucchi; Cristiano Alicino; Enrico Maria Tricarichi; Paola Del Giacomo; Mario Tumbarello
Journal:  Crit Care       Date:  2016-08-27       Impact factor: 9.097

Review 10.  Spatial and temporal analyses to investigate infectious disease transmission within healthcare settings.

Authors:  G S Davis; N Sevdalis; L N Drumright
Journal:  J Hosp Infect       Date:  2014-02-26       Impact factor: 3.926

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.